Disclosed positions
| REVOLUTION MEDICINES INC | RVMD | COM | $1,191,348,571 | 6,361,323 | SH | None |
| NUVALENT INC | NUVL | COM | $731,667,476 | 5,924,433 | SH | None |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $415,053,937 | 10,215,455 | SH | None |
| GENMAB A/S | GMAB | SPONSORED ADS | $360,767,109 | 13,133,131 | SH | None |
| SPYRE THERAPEUTICS INC | SYRE | COM NEW | $340,984,271 | 3,840,778 | SH | None |
| APOGEE THERAPEUTICS INC | APGE | COM | $209,233,581 | 1,576,385 | SH | None |
| ORUKA THERAPEUTICS INC | ORKA | COM | $204,094,539 | 2,144,526 | SH | None |
| TANGO THERAPEUTICS INC | TNGX | COM | $198,736,169 | 6,357,523 | SH | None |
| BELITE BIO INC | BLTE | SPONSORED ADS | $189,844,565 | 1,232,877 | SH | None |
| ERASCA INC | ERAS | COM | $174,956,000 | 9,550,000 | SH | None |
| TARSUS PHARMACEUTICALS INC | TARS | COM | $174,699,348 | 2,775,649 | SH | None |
| ALNYLAM PHARMACEUTICALS INC | ALNY | COM | $144,494,400 | 480,000 | SH | None |
| INSMED INC | INSM | COM PAR $.01 | $141,375,668 | 1,325,977 | SH | None |
| MBX BIOSCIENCES INC | MBX | COM | $138,442,428 | 2,508,015 | SH | None |
| VAXCYTE INC | PCVX | COM | $123,692,037 | 2,127,852 | SH | None |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $123,515,986 | 6,723,788 | SH | None |
| OLEMA PHARMACEUTICALS INC | OLMA | COM | $108,468,906 | 8,670,576 | SH | None |
| JADE BIOSCIENCES INC | JBIO | COM NEW | $63,491,539 | 2,857,405 | SH | None |
| TYRA BIOSCIENCES INC | TYRA | COM | $58,405,708 | 1,828,607 | SH | None |
| ASSEMBLY BIOSCIENCES INC | ASMB | COM NEW | $42,696,995 | 1,553,748 | SH | None |
| EYEPOINT INC | EYPT | COM NEW | $41,332,677 | 2,890,397 | SH | None |
| ACHIEVE LIFE SCIENCE INC | ACHV | COM | $32,335,620 | 4,951,856 | SH | None |
| VOR BIOPHARMA INC | VOR | COM NEW | $32,217,500 | 1,750,000 | SH | None |
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $24,580,936 | 685,852 | SH | None |
| KARDIGAN INC | KARD | COM | $21,465,000 | 900,000 | SH | None |
| LEXEO THERAPEUTICS INC | LXEO | COM | $19,436,403 | 4,175,382 | SH | None |
| EDITAS MEDICINE INC | EDIT | COM | $18,100,665 | 5,586,625 | SH | None |
| INVENTIVA SA | IVA | ADS | $15,120,000 | 4,000,000 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.